Literature DB >> 30562654

Seizures as a clinical manifestation in somatic autoimmune disorders.

Man Amanat1, Roland D Thijs2, Mona Salehi1, Josemir W Sander3.   

Abstract

The risk of epileptic seizures seems increased in several systemic autoimmune disorders including systemic lupus erythematosus, type 1 diabetes mellitus, myasthenia gravis, celiac disease, rheumatoid arthritis, Hashimoto's encephalopathy, psoriasis, multiple sclerosis, neuromyelitis optica, and bullous pemphigoid. Immune dysfunction may be partly responsible for this association. Elevated levels of pro-inflammatory cytokines, autoantibodies seen in these autoimmune disorders and antibodies against neuronal antigens may contribute to the etiopathogenesis of seizures and epilepsy associated to immune conditions. Other unknown factors, the effect of different co-morbid conditions of epilepsy as well as shared risk factors such as common etiological factors, environmental triggers, or a common genetic predisposition may also explain the association. We review different autoimmune disorders which may present with co-morbid seizures and discuss possible underlying mechanisms of this co-occurrence focusing on a potential role of immune system dysfunction.
Copyright © 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Comorbidity; Cytokines; Epilepsy; Lupus erythematosus; Type 1 diabetes mellitus

Mesh:

Year:  2018        PMID: 30562654     DOI: 10.1016/j.seizure.2018.11.012

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  2 in total

1.  Risk of epilepsy in rheumatoid arthritis: a meta-analysis of population based studies and bioinformatics analysis.

Authors:  Huawei Zhao; Shan Li; Meijuan Xie; Rongrong Chen; Haimei Lu; Chengping Wen; Anthony J Filiano; Zhenghao Xu
Journal:  Ther Adv Chronic Dis       Date:  2020-02-07       Impact factor: 5.091

2.  The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.

Authors:  Johannes J Rasker; Frederick Wolfe; Ewa G Klaver-Krol; Machiel J Zwarts; Peter M Ten Klooster
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.